AbCellera announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL635, an investigational antibody antagonist targeting ...

Quandri, developers of an AI automation platform modernizing personal lines renewals for insurance brokerages, announced the appointment of Heather Natour as its new Vice President of Engineering.